EuroEyes International Eye Clinic : PROFIT ALERT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

EuroEyes International Eye Clinic Limited

德視佳國際眼科有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1846)

PROFIT ALERT

This announcement is made by EuroEyes International Eye Clinic Limited (the "Company", together with its subsidiaries, the "Group") pursuant to Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules") and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

The board of directors (the "Board") of the Company wishes to inform the shareholders of the Company (the "Shareholders") and potential investors that, based on the unaudited consolidated management accounts of the Group for the six months ended 30 June 2020, the Group expects to record a profit attributable to owners of the Company in the region between HK$17.0 million to HK$20.0 million, an overall increase of over 250% as compared to the corresponding period in 2019. After adjusting for the one-offnon-deductible listing expenses of approximately HK$18.6 million being recognised for the six months ended 30 June 2019, a decrease of approximately 24% in profit attributable to owners of the Company is expected to be recorded for the six months ended 30 June 2020 as compared to the corresponding period in 2019. This decrease is due to the impact of the COVID-19 outbreak in which the Group's business operations in the PRC, but also in Germany and Denmark to a lesser degree, were affected.

The Group is recovering from the COVID-19 outbreak. However the upcoming performance will depend on whether the COVID-19 outbreak will be under control in the relevant markets that the Group operates.

The Company is still in the process of finalising the consolidated results of the Group for the six months ended 30 June 2020. The information contained in this announcement is only a preliminary assessment by the Board based on information that is currently available to it, which was neither audited nor reviewed by the Company's auditor or the audit committee of the Board. The actual results of the Group for the six months ended 30 June 2020 may be different from what is indicated in this announcement.

1

Shareholders and potential investors of the Company should refer to the interim results announcement of the Company for the six months ended 30 June 2020, which is expected to be published by the end of August 2020.

Shareholders and potential investors of the Company are advised to exercise caution when dealing in the shares of the Company.

By Order of the Board

EuroEyes International Eye Clinic Limited

Dr. Jørn Slot Jørgensen

Chairman and Executive Director

Hong Kong, 19 August 2020

As at the date of this announcement, the board of Directors comprises Dr. Jørn Slot Jørgensen, Dr. Markus Braun, Dr. Ralf-Christian Lerche, Prof. Dr. Thomas Friedrich Wilhelm Neuhann, Mr. Jannik Jonas Slot Jørgensen as executive Directors; Mr. Marcus Huascar Bracklo as non-executive Director; Mr. Hans Helmuth Hennig, Mr. Zhengzheng Hu and Mr. Philip Duncan Wright as independent non-executive Directors.

2